Patents by Inventor Kenneth Mayo

Kenneth Mayo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240159743
    Abstract: Provided herein are methods for assessing cell surface glycans, e.g., N-glycans, by assessing a sample of released surface glycans, and determining the presence, absence, or level of glycans present in the sample. Also provided are methods of assaying and/or evaluating a cell composition by assessing the cell surface glycan profile of the cell composition and comparing the profile to a reference sample. Methods for manufacturing and/or culturing a plurality of cell compositions having consistent surface glycan expression with low variability are also provided.
    Type: Application
    Filed: September 15, 2023
    Publication date: May 16, 2024
    Applicant: Juno Therapeutics, Inc.
    Inventors: Paul Ken KODAMA, Tom KOWSKI, Mirna MUJACIC, Kenneth Mayo PRENTICE
  • Patent number: 11796534
    Abstract: Provided herein are methods for assessing cell surface glycans, e.g., N-glycans, by assessing a sample of released surface glycans, and determining the presence, absence, or level of glycans present in the sample. Also provided are methods of assaying and/or evaluating a cell composition by assessing the cell surface glycan profile of the cell composition and comparing the profile to a reference sample. Methods for manufacturing and/or culturing a plurality of cell compositions having consistent surface glycan expression with low variability are also provided.
    Type: Grant
    Filed: April 13, 2018
    Date of Patent: October 24, 2023
    Assignee: Juno Therapeutics, Inc.
    Inventors: Paul Ken Kodama, Tom Kowski, Mima Mujacic, Kenneth Mayo Prentice
  • Publication number: 20220050114
    Abstract: Provided herein are methods for generating a mass spectrometry (MS) profile of a sample from a cell composition, such as an engineered cell composition. In some embodiments, the mass spectrometry profile includes data based on one or more mass spectrometry analyses or techniques. Also provided herein are methods for, based on mass spectrometry profiles of one or more samples of such cell compositions: identifying a mass spectrometry (MS) profile of a genetically engineered cell composition comprising immune cells comprising a recombinant receptor by comparison to a reference mass spectrometry profile; characterizing a process for producing genetically engineered cell composition; assessing cell surface proteins of an engineered cell composition; and assessing a process for producing a genetically engineered cell composition.
    Type: Application
    Filed: September 11, 2019
    Publication date: February 17, 2022
    Applicant: JUNO THERAPEUTICS, INC.
    Inventor: Kenneth Mayo PRENTICE
  • Publication number: 20210255173
    Abstract: Provided herein are methods for assessing cell surface glycans, e.g., N-glycans, by assessing a sample of released surface glycans, and determining the presence, absence, or level of glycans present in the sample. Also provided are methods of assaying and/or evaluating a cell composition by assessing the cell surface glycan profile of the cell composition and comparing the profile to a reference sample. Methods for manufacturing and/or culturing a plurality of cell compositions having consistent surface glycan expression with low variability are also provided.
    Type: Application
    Filed: April 13, 2018
    Publication date: August 19, 2021
    Applicant: Juno Therapeutics, Inc.
    Inventors: Paul Ken KODAMA, Tom KOWSKI, Mirna MUJACIC, Kenneth Mayo PRENTICE
  • Patent number: D711650
    Type: Grant
    Filed: May 11, 2012
    Date of Patent: August 26, 2014
    Inventors: Wade R. Costello, Kenneth Mayo